Adolescents with type 1 diabetes can achieve glycemic targets on intensive insulin therapy without excessive weight gain.

BMI-SDS did not increase with the change to intensive insulin therapy despite a doubling in the number of adolescents achieving the recommended glycemic target of <7.0% (53 mmol/mol). HbA1c was not associated with weight gain.